( 1) ,..., R 0 (K) as S 1 (We used K=1000 in our study); 4. Replacing S 0 with S 1 , redo (1), (2), and (3); in (3), instead of keeping all probes appeared, we now keep only the ones with occurrence rate (the ratio of times being selected and times being sampled) over 50%; 5. Repeating (4) until some iteration n where the size of S n is either the same as S n-1 or smaller than a predefined number (50 as default). S n is the final set of probes discovered by RSS. 6. Training random Forest using probes in S n then use importance to rank the probes in S n . Because our datasets are unbalanced (more patients with RD than pCR), we used F 0.5 -score, positive precision and positive recall to measure model performance. F 0.5 -score is defined as (1+0.5
2 )precisionrecall/(0.5 2 *precision + recall), where precision is defined as (number of patients who are predicted to be pCR and observed to be pCR)/(number of patients who are predicted to be pCR), and recall is defined as (number of patients who are predicted to be pCR and observed to be pCR)/(number of patients who are observed to be pCR). F 0.5 -scores were calculated from a 5-fold cross-validation, where we conducted RSS on each training fold to obtain the candidate sets: S n1 , ..., S n5 . To select significant probes to a model and evaluate the model, we first added the probes one at a time (from highest ranked) to the clinical-model with only clinical variables (age, ER-status, HER2-status, t-stage, and n-stage). Then we recorded F 0.5 -score along the path. The optimal number of probes for the model was chosen to be the number of probes corresponding to the maximum F 0.5 -score for first N probes (we used N=30).
Simulation study
To generate simulated data, first the pCR to RD ratio was set to be 200:800 and 100:900 (pCR:RD) to mimic the situation that in the real data in which there are more RD than pCR. For the predictors, 10 informative predictors ( 1 , … , 10 ) 990 non-informative predictors ( 11 , … , 1000 ) were included, and three scenarios were considered: 1). All predictors were independent and uncorrelated, there was a mean upshift for K samples (100 or 200) and downshift for 1000-K samples for the informative predictors, but the means were 0 for all non-informative predictors, that is
Where represents the th sample. 2). Like 1) but the informative predictors are correlated, ∼ ( , Σ) Where = 0.5 ≤ ≤10 − 0.5 > ≤10 , and Σ = (−0.9) | − | (Σ is the entry on the th row and th column of Σ) 3) based on 1), but we imposed an interaction pattern:
The responses were naturally assigned as 1 or -1 (pCR or RD respectively). We compared our method with LASSO on logistic regression. 10-fold cross validation was used to evaluate the performances.
Cell line validation
We collected data for 21 cell lines (some with replicates), among which 18 are paclitaxel sensitive and 3 are paclitaxel resistant (Table S17) . We used our model to predict the probabilities of these cell lines to be pCR, then test the hypothesis 0 : = 1 : < , where and represent the mean probabilities of the resistant cell lines to achieve pCR and the mean probabilities of the sensitive cell lines to achieve pCR, respectively. A Welch's two sample t-test gives the p-value 0.0108; therefore, we reject the null hypothesis. One could also tell the probabilities being pCR of the paclitaxel sensitive group is significantly higher than the ones of the paclitaxel resistant group from the boxplots (Figure 2 ) for the two groups. 
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. The left side of each bar plot is the original assignment, and the right side is the PRES assignment 
